GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » YoY Rev. per Sh. Growth

Kilitch Drugs (India) (BOM:524500) YoY Rev. per Sh. Growth : 36.10% (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Kilitch Drugs (India)'s YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 36.10%.

Kilitch Drugs (India)'s Revenue per Share for the three months ended in Mar. 2025 was ₹38.02.


Kilitch Drugs (India) YoY Rev. per Sh. Growth Historical Data

The historical data trend for Kilitch Drugs (India)'s YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) YoY Rev. per Sh. Growth Chart

Kilitch Drugs (India) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.11 64.88 22.80 8.79 27.17

Kilitch Drugs (India) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.58 -11.52 15.98 72.90 36.10

Kilitch Drugs (India) YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Kilitch Drugs (India)'s YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2025 )
=(Revenue per Share (A: Mar. 2025 )-Revenue per Share (A: Mar. 2024 ))/ | Revenue per Share (A: Mar. 2024 ) |
=(123.294-96.949)/ | 96.949 |
=27.17 %

Kilitch Drugs (India)'s YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(38.024-27.938)/ | 27.938 |
=36.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kilitch Drugs (India) YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines